|Bid||46.21 x 1100|
|Ask||56.70 x 800|
|Day's range||51.93 - 54.12|
|52-week range||40.69 - 115.33|
|Beta (5Y monthly)||1.22|
|PE ratio (TTM)||21.37|
|Earnings date||07 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||69.33|
Catalent (NYSE:CTLT) has had a great run on the share market with its stock up by a significant 19% over the last...
Taro (TARO) delivered earnings and revenue surprises of -78.16% and 14.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
SOMERSET, N.J., January 20, 2023--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it will release financial results for the second quarter of fiscal year 2023 ended December 31, 2022, before the market open on Tuesday, February 7, 2023. The Company’s management will host a webcast to discuss the results at 8:15 a.m. ET